One- and two-year overall survival following stereotactic body radiotherapy versus conventional radiotherapy for pancreatic cancer: a systematic review and meta-analysis
SBRT is associated with superior 1- and 2-year OS versus CRT in pancreatic cancer. These findings warrant further prospective validation to optimize integration in contemporary treatment algorithms.
Authors
- Dapeng Kuang
- Mengqi Yang (ORCID: https://orcid.org/0000-0002-2161-1973)
- Yedong Huang
- Shasha Fan (ORCID: https://orcid.org/0000-0002-5975-8081)
- Songwen Tan
- Yajun Zhao (ORCID: https://orcid.org/0000-0003-4289-9766)
- Yujia Huo
- Lin Zhang (ORCID: https://orcid.org/0000-0002-2064-8440)
Institutions
- Fujian Medical University (CN)
- Sun Yat-sen University (CN)
- Hunan Normal University (CN)
- Shanghai Jiao Tong University (CN)
- Fudan University (CN)
- Suzhou Research Institute (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Shanghai First People's Hospital (CN)
- Hunan Provincial People's Hospital (CN)
- Monash University (AU)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1097/js9.0000000000003992
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00